✦ LIBER ✦

Conversion to neoral for tacrolimus-related adverse effects in liver transplant recipients and improvement in quality of life

✍ Scribed by R.H. Tolba; B. Wrigge; U. Machein; T. Minor; J.C. Kalff; A. Hirner; M. Wolff

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Conversion from tacrolimus to neoral in

✍ R Ott; M Bussenius-Kammerer; D Scholz; R Neuhaus; R.H Tolba; L Fricke; V Müller 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 50 KB

Treatment of tacrolimus-related adverse

✍ Sukru Emre; Yuri Genyk; Leona Kim Schluger; Thomas M. Fishbein; Stephen R. Guy; 📂 Article 📅 2000 🏛 Springer 🌐 English ⚖ 599 KB

Treatment of tacrolimus-related adverse

✍ S. Emre; Y. Genyk; L. K. Schluger; T. M. Fishbein; S. R. Guy; P. A. Sheiner; M. 📂 Article 📅 2000 🏛 Springer 🌐 English ⚖ 63 KB

Physical activity and health-related qua

✍ Patricia Painter; Joanne Krasnoff; Steven M. Paul; Nancy L. Ascher 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 238 KB

Adherence and health-related quality of

✍ Emily M. Fredericks; John C. Magee; Lisa Opipari-Arrigan; Victoria Shieck; Andre 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 177 KB

Reversal of tacrolimus-related hypertrop

✍ Anna Turska-Kmieć; Irena Jankowska; Joanna Pawłowska; Piotr Kaliciński; Wanda Ka 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 496 KB